British Lung Foundation — CureCurrent

How to interpret these research links

Connected source records

The exact organization name British Lung Foundation appears in 11 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials11

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

11 shown

Niraparib Efficacy in Patient With Unresectable MesotheliomaNCT05455424 · collaborator · 2022-07-11

Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant MesotheliomaNCT03654833 · collaborator · 2019-01-28

Physical Activity Following Pulmonary Rehabilitation in COPDNCT03660644 · collaborator · 2018-06-13

Computed Tomography Assessment of Regional Ventilation (CURVE)NCT02879773 · collaborator · 2016-01-22

Malignant Mesothelioma - Can we Improve Quality of LifeNCT03068117 · collaborator · 2014-04-03

Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility StudyNCT01836692 · collaborator · 2014-04-01

Launching an Asthma Initiative Designed to Improve Asthma Management and OutcomesNCT02140671 · collaborator · 2012-05-01

Metformin in Chronic Obstructive Pulmonary DiseaseNCT01247870 · collaborator · 2011-01-01

Early Pulmonary Rehabilitation Following Acute COPD ExacerbationNCT00557115 · collaborator · 2006-01-01

The Use of Inflammatory Markers to Guide Therapy in Children With Severe AsthmaNCT00262340 · collaborator · 2005-12-01

Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary CareNCT00440687 · collaborator · 2001-01-01

Sponsor roles

collaborator11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.